Len Blavatnik, 10% Owner at Day One Biopharmaceuticals, Inc. (DAWN), bought 1,200,000 shares at $15.00 ($18.0M) on 2022-06-17, disclosed to the SEC on 2022-06-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| LYB | SELL | 2022-12-05 | $242.4M | — | Filing → |
| VRNA | BUY | 2022-08-17 | $6.3M | — | Filing → |
| WMG | SELL | 2022-01-07 | $696.3M | — | Filing → |